Spyre Therapeutics
Price & Volume
Stats
See more52W Range | $14.50-$110.17 |
Market Cap | $7.8B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$215.7M |
Diluted EPS | -$1.92 |
News
See moreYahoo Finance • yesterday
Boston Scientific (BSX) Didn’t Miss on Demand or Devices. A Cyberattack Just Broke Its Guidance.
Yahoo Finance • yesterday
Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question.
Yahoo Finance • 11 days ago
Spyre Therapeutics (SYRE) Down 16.6% Since Last Earnings Report: Can It Rebound?
Yahoo Finance • 21 days ago
Is SYRE a Buy Now as Clinical Catalysts Clash With Valuation Risk?
About
CEO | Dr. Cameron Turtle DPHIL, Ph.D. |
Address | Building 23, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 125 |